UNITED STATES: Corporate 'litigation risk' will fall
You must be signed in to read this analysis
In this article
- Crucial test case
- Medical devices
- Rezulin
- Momentous implications
- Industrial extension
- Impact on law firms
- Other drug industry victories
- New Jersey decision
- Texas ruling
- Merck's strategy vindicated?
- Business legal strategy
- Trial lawyers counterattack?
What is this?
This article is from the Oxford Analytica Daily Brief, which analyses geopolitical, economic, social, business and industrial developments on a global and regional basis, providing clients with timely, authoritative analysis every business day of the year. Find out more about the Oxford Analytica Daily Brief, or request a trial.